Open-Label Study Evaluating Synera® in the Treatment of Patients With Carpal Tunnel Syndrome

Phase 2 Completed 24 enrolled ZARS Pharma Inc.

NaSingle-groupOpen-labelTreatment

Summary

The purpose of the study is to explore the potential usefulness of Synera for the treatment of pain associated with mild to moderate carpal tunnel syndrome.

Timeline

Start: 2009-09
Primary completion: 2010-03
Completion: 2010-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Synera	Unknown	70 mg	Topical

Open-Label Study Evaluating Synera® in the Treatment of Patients With Carpal Tunnel Syndrome

Summary

Timeline

Drugs

Indications